• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number D-EVOLUTFX-34
Medical Device Problem Codes Failure to Advance (2524); Material Twisted/Bent (2981)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/21/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that prior to the attempted implant of a transcatheter valve via femoral access, a balloon dilation was performed at the iliac arteries due to the patient's thick calcification using an 8 millimeter (mm) balloon twice.It was noted that the minimal diameter of the access vessel was 5 mm.Upon delivery catheter system (dcs) insertion, the dcs was unable to advance through the vessels, and a bend in the capsule was observed.Three attempts were made to advance the dcs; however, a scratch was noted on the cover of the dcs.The physician noted the patient's calcification was hard and sharp.Subsequently, the valve was not implanted in the patient.No patient complications were reported as a result of this event.
 
Additional Manufacturer Narrative
Select patient information cannot be included in the regulatory report due to regional privacy regulations.Continuation of d10: product id: {evolutfx-34}; product lot/serial number: {(b)(6)}; product type: {0195-heartvalves}; implant date: {n/a}; explant date: {n/a}.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Updated data: b5 additional codes.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Additional information was received that during the valve procedure, as the first delivery catheter system (dcs) was unable to advance through the patient's calcified anatomy.Scratches approximately 1 centimeter on the first dcs was noted around the middle of the capsule.Subsequently, a new valve and dcs were used through direct aortic access resulting in a procedure delay.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT FX DCS
Common Device Name
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key23634295
Report Number9612164-2025-05813
Device Sequence Number13340688
Product Code NPT
UDI-Device Identifier00763000365684
UDI-Public(01)00763000365684(17)270123(10)0012637273(20)01
Combination Product (Y/N)N
Initial Reporter CountryRP
PMA/510(K) Number
P130021
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/10/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberD-EVOLUTFX-34
Device Catalogue NumberD-EVOLUTFX-34
Device Lot Number0012637273
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/21/2025
Supplement Date Received by Manufacturer12/03/2025
Initial Report FDA Received Date11/24/2025
Supplement Report FDA Received Date12/10/2025
Date Device Manufactured01/23/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11...
Patient Age72 YR
Patient SexMale
-
-